Cystic Fibrosis (CF) is a progressive genetic disease that affects the lungs, digestive system, pancreas and other organ systems. It causes thick, sticky mucus to build up in the lungs, which can lead to life-threatening infections. The projected life expectancy for someone with CF is mid-30s. In the US alone, there are 30,000 people with CF.
Since the 1950s, the Cystic Fibrosis Foundation (CFF) has vigorously sought a cure for CF with innovative research, fundraising, the creation of a network of accredited care centers and progressive partnerships with biotech companies. Through it all, the CFF has strived to make people with CF live longer and better. In the past 50 years, the CFF has achieved remarkable success.
Various renowned publications, universities and organizations have recognized the CFF’s outstanding efforts. The CFF drug development model has been praised by publications such as Forbes, The New Yorker and Bloomberg BusinessWeek as well as Harvard Business School. The Foundation is an accredited charity of the Better Business Bueareau’s Wise Giving Alliance.
The CFF is a forerunner in efficiency with more than 88 cents of every revenue dollar raised going directly to CF research, care and education.